Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: Final analysis of a multicentre, open-label, early-access protocol trial

  1. Sternberg, C.N.
  2. Castellano, D.
  3. Daugaard, G.
  4. Géczi, L.
  5. Hotte, S.J.
  6. Mainwaring, P.N.
  7. Saad, F.
  8. Souza, C.
  9. Tay, M.H.
  10. Garrido, J.M.T.
  11. Galli, L.
  12. Londhe, A.
  13. De Porre, P.
  14. Goon, B.
  15. Lee, E.
  16. McGowan, T.
  17. Naini, V.
  18. Todd, M.B.
  19. Molina, A.
  20. George, D.J.
Aldizkaria:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Argitalpen urtea: 2014

Alea: 15

Zenbakia: 11

Orrialdeak: 1263-1268

Mota: Artikulua

DOI: 10.1016/S1470-2045(14)70417-6 GOOGLE SCHOLAR